IMARC Group, a leading market research company, has recently released a report titled “Aptamers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global aptamers market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the aptamers market?
The global aptamers market size reached US$ 2.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.5 Billion by 2028, exhibiting a growth rate (CAGR) of 20.6% during 2023-2028.
What is the aptamers?
Aptamers are short, single-stranded DNA or RNA molecules that can specifically bind to target molecules with high affinity and specificity. They are generated through an in vitro selection process called Systematic Evolution of Ligands by Exponential Enrichment (SELEX), which allows for the identification of aptamers that bind to a wide range of targets, including proteins, small molecules, and even cells. Aptamers have several advantages over traditional antibodies, such as ease of synthesis, low immunogenicity, and stability. They have a wide range of applications in diagnostics, therapeutics, and research, and are being actively explored as an effective alternative to antibodies in various fields.
Aptamers Market Trends:
The increasing demand for diagnostic and therapeutic applications including cancer diagnosis and treatment, drug discovery, and personalized medicine represents a key factor driving the market growth across the globe. In line with this, advancements in SELEX technology are contributing to the growth of the market as it allows for the identification of aptamers with higher specificity and affinity. The market is also driven by increasing research and development (R&D) activities in the field of aptamers. This is primarily attributed to its various advantages, such as low cost of manufacturing, low immunogenicity, small molecular size, and lesser side effects as compared to antibodies that boost the research and development of novel aptamers. Apart from this, the increasing demand for protein therapeutics to improve their efficacy and specificity is creating a positive outlook for the market.
Request to Get the Sample Report: https://www.imarcgroup.com/aptamers-market/requestsample
Aptamers Market 2023-2028 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the global aptamers market has been studied in the report with the detailed profiles of the key players operating in the market.
Aptamers Market Key Companies:
- Aptagen LLC
- Aptamer Group
- Aptamer Sciences Inc.
- Aptus Biotech S.L.
- Base Pair Biotechnologies Inc.
- IBA GmbH
- Kaneka Eurogentec S.A. (Kaneka Corporation)
- NeoVentures Biotechnology Inc.
- NOXXON Pharma
- SomaLogic Inc.
- TriLink BioTechnologies LLC
- Vivonics Inc.
Report Segmentation:
The report has segmented the global aptamers market on the basis of type, application and region.
Breakup by Type:
- Nucleic Acid
- Peptide
Breakup by Application:
- Diagnostics
- Therapeutics
- Research and Developments
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Speak to Analysis: https://www.imarcgroup.com/request?type=report&id=3845&flag=C
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
Read Newsletter: https://www.linkedin.com/newsletters/industry-news-about-6929400456628637696